We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at ...

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $26.61, moving +1.88% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.58%. On ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 26, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts ...

Asked to comment, session moderator Jaime Almandoz, MD, associate professor of internal medicine ... Therapeutics, Gan & Lee Pharmaceuticals, Regeneron, Epitomee, Neurovalens, Viking Therapeutics ...

The European company is a potential competitor because, similarly, Viking has gained a degree of fame with its VK2735, an investigational weight-loss treatment. The medicine performed exceedingly ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are covering the firm, Marketbeat reports.

What started as off-label use by celebrities and social media influencers for cutting weight became a viral sensation as type 2 diabetes medicine ... from Viking Therapeutics Inc. VKTX that ...

Sanctuary Advisors LLC grew its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 51.3% in the third quarter, HoldingsChannel reports. The fund owned 5,416 shares of ...